Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Gautam Borthakur
Prognostic Significance of Hyperdiploidy in Adult Acute Myeloid Leukemia
American Journal of Hematology
Hematology
NPM1 Mutant Variant Allele Frequency Correlates With Leukemia Burden but Does Not Provide Prognostic Information in NPM1-mutated AML
American Journal of Hematology
Hematology
Prognostic Significance of Additional Chromosomal Abnormalities at the Time of Diagnosis in Patients With Chronic Myeloid Leukemia Treated With Frontline Tyrosine Kinase Inhibitors
American Journal of Hematology
Hematology
Prognosis of Patients With Intermediate Risk IPSS-R Myelodysplastic Syndrome Indicates Variable Outcomes and Need for Models Beyond IPSS-R
American Journal of Hematology
Hematology
Therapeutic Targeting of Isocitrate Dehydrogenase Mutant AML
Expert Opinion on Investigational Drugs
Medicine
Pharmacology
MDM2 Inhibitor, Nutlin 3a, Induces P53 Dependent Autophagy in Acute Leukemia by AMP Kinase Activation
PLoS ONE
Multidisciplinary
Patient-Driven Discontinuation of Tyrosine Kinase Inhibitors: Single Institution Experience
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
Tyrosine Kinase Inhibitors as Initial Therapy for Patients With Chronic Myeloid Leukemia in Accelerated Phase
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Phase I and Extension Study of Clofarabine Plus Cyclophosphamide in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Phase I Study of S-Trans, Trans-Farnesylthiosalicylic Acid (Salirasib), a Novel Oral RAS Inhibitor in Patients With Refractory Hematologic Malignancies
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
‹
1
2
3
›
